Open AccessImaging of prostate cancer
Author(s) -
HeinzPeter Schlemmer,
Bernd J. Krause,
Viktoria Schütz,
David Bonekamp,
Sarah M. Schwarzenböck,
Markus Hohenfellner
Publication year - 2021
Publication title -
deutsches ärzteblatt international
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.436
H-Index - 60
ISSN - 1866-0452
DOI - 10.3238/arztebl.m2021.0309
Subject(s) - medicine , overdiagnosis , prostate cancer , rectal examination , biopsy , prostate biopsy , transrectal ultrasonography , prostate , radiology , magnetic resonance imaging , cancer , prostate specific antigen
Prostate cancer is the most common type of solid tumor in men and the second most common cause of cancer-related death in males in Germany. The conventional strategy for its primary detection, i.e., systematic ultrasound-guided prostate biopsy in men who have elevated PSA levels and/or positive findings on digital rectal examination, fails to reveal all cases. The same is true of the use of conventional computed tomography (CT), magnetic resonance imaging (MRI), and skeletal scintigraphy for the early detection of recurrences and distant metastases.